Project

The VIVA Research Programme is at the forefront of cancer treatment innovation, driven by our commitment to translational research and comprehensive training. We are focused on developing groundbreaking cellular and gene therapies for leukemia and solid tumors, investigating pioneering tumor vaccination and antibody research, and enhancing clinical protocols through cutting-edge translational research. Our training programs provide comprehensive education in CAR T-cell therapy and related technologies, regional training for clinicians and nurses at KK Women’s and Children’s Hospital (KKH), and technician training at the VIVA Research Lab. By fostering a collaborative environment, we aim to accelerate the discovery of new treatments, improve patient outcomes, and transform the lives of those affected by cancer.